Breaking News, Financial News

Financial Report: Albany Molecular Research, Inc.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

AMRI 4Q Revenues: $46.6 million (+19%) 4Q Loss: $764,000 (loss was $942,000 in 4Q2005) FY Revenues: $179.8 million (-2%) FY Earnings: $2.2 million (earnings were $16.3 million FY2005) Comments: Total contract revenue for the year was up 23% to $40.3 million. In the quarter contract revenue from discovery services was $12.2 million, up 52% driven primarily by revenue resulting from the acquisition of ComGenex, and for the year was $39.6 million, up 44%. Contract revenue from de...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters